在三种不同Lynch综合征监测政策的国家中,结肠镜检查发现的结直肠癌发病率或分期无差异
该研究比较了德国(每年1次)、荷兰(1–2年间隔)和芬兰(2–3年间隔)的Lynch综合征结肠镜监测政策。共纳入2747例患者、16327次结肠镜检查、23309人年累积观察时间,未发现各国间结直肠癌累积发病率或检出时分期有显著差异,也未发现监测间隔与结直肠癌风险有显著关联。
要点
- 德国每年1次、荷兰1–2年、芬兰2–3年的结肠镜监测间隔下,结直肠癌累积发病率和检出分期无显著差异。
- 10年累积结直肠癌发病率在低危和高危特征患者中分别为4.1%和18.4%,并随年龄、性别、突变和既往肿瘤史变化。
- 未发现监测间隔与结直肠癌风险有显著关联,但年龄、性别、突变和既往肿瘤用于个体化调整结肠镜间隔。
核心结论
- 德国每年结肠镜监测相比荷兰1–2年间隔和芬兰2–3年间隔,未发现结直肠癌发病率或检出分期的显著降低。
- 总体未发现监测间隔与结直肠癌风险有显著关联,尽管年龄、性别、突变和既往肿瘤被用于个体化调整结肠镜间隔。
- 需要研究来开发和验证风险适应性监测策略,并识别从更短监测间隔中获益的患者。
研究设计与样本
- 收集德国HNPCC联盟、荷兰Lynch综合征登记和芬兰Lynch综合征登记中2747例Lynch综合征患者(MLH1、MSH2或MSH6基因致病性变异)的16327次结肠镜检查数据,检查时间1984年至2015年。
- 分析包括23309人年累积观察时间。
- 从索引结肠镜到发生结直肠癌或腺瘤的时间采用Kaplan-Meier法分析,组间比较采用log-rank检验。
- 采用多变量Cox回归分析识别与结直肠癌风险相关的因素(索引结肠镜前结直肠癌诊断、性别、突变、年龄、索引结肠镜时腺瘤存在)。
主要发现
- 10年累积结直肠癌发病率在低危和高危特征患者中分别为4.1%和18.4%,并随年龄、性别、突变和既往结直肠癌或腺瘤检出而变化。
- 观察到的结肠镜间隔基本符合各国推荐。
- 各国间结直肠癌累积发病率或检出时结直肠癌分期无显著差异。
- 结直肠癌分期与距末次结肠镜时间无显著关联。
局限性
- 需要研究来开发和验证风险适应性监测策略,并识别从更短监测间隔中获益的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Patients with Lynch syndrome are at high risk for developing colorectal cancer (CRC). Regular colonoscopic surveillance is recommended, but there is no international consensus on the appropriate interval. We investigated whether shorter intervals are associated with lower CRC incidence and detection at earlier stages by comparing the surveillance policies in Germany, which evaluates patients by colonoscopy annually, in the Netherlands (patients evaluated at 1-2-year intervals), and Finland (patients evaluated at 2-3-year intervals). METHODS: We collected data from 16,327 colonoscopic examinations (conducted from 1984 through 2015) of 2747 patients with Lynch syndrome (pathogenic variants in the MLH1, MSH2, or MSH6 genes) from the German HNPCC Consortium, the Dutch Lynch Syndrome Registry, and the Finnish Lynch Syndrome Registry. Our analysis included 23,309 person-years of cumulative observation time. Time from the index colonoscopy to incident CRC or adenoma was analyzed using the Kaplan-Meier method; groups were compared using the log-rank test. We performed multivariable Cox regression analyses to identify factors associated with CRC risk (diagnosis of CRC before the index colonoscopy, sex, mutation, age, and presence of adenoma at the index colonoscopy). RESULTS: The 10-year cumulative CRC incidence ranged from 4.1% to 18.4% in patients with low- and high-risk profiles, respectively, and varied with age, sex, mutation, and prior detection of CRC or adenoma. Observed colonoscopy intervals were largely in accordance with the country-specific recommendations. We found no significant differences in cumulative CRC incidence or CRC stage at detection among countries. There was no significant association between CRC stage and time since last colonoscopy. CONCLUSIONS: We did not find a significant reduction in CRC incidence or stage of detection in Germany (annual colonoscopic surveillance) than in countries with longer surveillance intervals (the Netherlands, with 1-2-year intervals, and Finland, with 2-3-year intervals). Overall, we did not find a significant association of the interval with CRC risk, although age, sex, mutation, and prior neoplasia were used to individually modify colonoscopy intervals. Studies are needed to develop and validate risk-adapted surveillance strategies and to identify patients who benefit from shorter surveillance intervals.
引用
- Engel C, Vasen HF, Seppälä T, et al. No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies. Gastroenterology. 2018. PMID: 30063918. doi:10.1053/j.gastro.2018.07.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。